Sarah Brendler, MD
Gastroenterology · Corvallis, ORNPI 1609827278
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 30.9% of the total. Reporting peaked in 2019 at $1,924 and has fallen 96.7% since, to $63 in 2024.
Across 199 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$540
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$437
- Takeda Pharmaceuticals U.S.A., Inc.$292
- E.r. Squibb & Sons, L.L.C.$166
- Braintree Laboratories, Inc.$132
- plus $767 from 19 others
What the payments were for
- Consulting fees$171%
- Food & beverage$3,36299%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,045 |
| Johnson & Johnson | 43 | $540 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $437 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $292 |
| E.r. Squibb & Sons, L.L.C. | 2 | $166 |
| Braintree Laboratories, Inc. | 6 | $132 |
| Shionogi Inc | 4 | $76 |
| Lilly USA, LLC | 5 | $73 |
| GSK | 3 | $64 |
| Ferring Pharmaceuticals Inc. | 3 | $56 |
| Intercept Pharmaceuticals, Inc. | 3 | $54 |
| Ironwood Pharmaceuticals, Inc | 4 | $52 |
| Pacira Therapeutics, Inc. | 2 | $51 |
| Janssen Scientific Affairs, LLC | 1 | $49 |
| Merck | 3 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Pfizer | 2 | $35 |
| Gilead | 1 | $34 |
| Novartis | 2 | $32 |
| UCB, Inc. | 2 | $28 |
| Sobi, Inc | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Radius Health, Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Amgen | 1 | $11 |
How this compares
$3,379 in reported general payments places this provider in the 85th percentile of 220 gastroenterology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 13 | $819 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $288 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Corvallis
- Keith HarrisCorvallis$1K
- Donald LumPortland$320K
- Rebecca MatroPortland$154K
- Ian HolmesPortland$102K
- Amy ZhuPortland$72K
- Gregory CotePortland$58K
- Emily JonicaPortland$49K
- Rebecca FauselPortland$29K
- Anil SharmaPortland$14K
- Jennifer RodriguezGresham$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.